Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    enVVeno Medical Corporation (NVNOW)

    Price:

    0.01 USD

    ( - -0.00 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    NVNOW
    Name
    enVVeno Medical Corporation
    Industry
    Medical - Devices
    Sector
    Healthcare
    Price
    0.006
    Market Cap
    73.651M
    Enterprise value
    51.079M
    Currency
    USD
    Ceo
    Robert A. Berman
    Full Time Employees
    30
    Ipo Date
    2018-06-14
    City
    Irvine
    Address
    70 Doppler

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Abiomed, Inc.

    VALUE SCORE:

    0

    Symbol
    ABMD
    Market Cap
    17.181B
    Industry
    Medical - Devices
    Sector
    Healthcare

    2nd position

    PROCEPT BioRobotics Corporation

    VALUE SCORE:

    9

    Symbol
    PRCT
    Market Cap
    2.294B
    Industry
    Medical - Devices
    Sector
    Healthcare

    The best

    Viemed Healthcare, Inc.

    VALUE SCORE:

    11

    Symbol
    VMD
    Market Cap
    283.524M
    Industry
    Medical - Devices
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.882
    P/S
    23.703
    P/B
    0.616
    Debt/Equity
    0.027
    EV/FCF
    -0.985
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    22.272
    Earnings yield
    -1.133
    Debt/assets
    0.024
    FUNDAMENTALS
    Net debt/ebidta
    0.048
    Interest coverage
    0
    Research And Developement To Revenue
    14.557
    Intangile to total assets
    0
    Capex to operating cash flow
    -0.006
    Capex to revenue
    0.134
    Capex to depreciation
    0.210
    Return on tangible assets
    -0.631
    Debt to market cap
    0.046
    Piotroski Score
    1.000
    FUNDAMENTALS
    PEG
    0.525
    P/CF
    -1.102
    P/FCF
    -1.049
    RoA %
    -63.067
    RoIC %
    -73.284
    Gross Profit Margin %
    3.079
    Quick Ratio
    11.809
    Current Ratio
    11.809
    Net Profit Margin %
    -2.841k
    Net-Net
    1.554
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.902
    Revenue per share
    0.040
    Net income per share
    -1.133
    Operating cash flow per share
    -0.907
    Free cash flow per share
    -0.902
    Cash per share
    1.727
    Book value per share
    1.624
    Tangible book value per share
    1.624
    Shareholders equity per share
    1.624
    Interest debt per share
    0.043
    TECHNICAL
    52 weeks high
    0.230
    52 weeks low
    0.006
    Current trading session High
    0.010
    Current trading session Low
    0.006
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.545
    logo

    Country
    CH
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -8.249
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.882
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Devices
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.385
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Diagnostics & Research
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.644

    No data to display

    DESCRIPTION

    enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

    NEWS